Paul Evangelisti, MD
Otolaryngology/Facial Plastic Surgery · Sumter, SCNPI 1982625745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $549, 2.6 times the $214 reported in 2019.
Across 58 payments — averaging $29.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$325
- Amgen$189
- GSK$182
- Optinose US, Inc.$154
- Integra Lifesciences Corporation$126
- Idorsia Pharmaceuticals US Inc$112
- plus $632 from 20 others
What the payments were for
- Food & beverage$1,66497%
- Education$563%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 9 | $325 |
| Amgen | 2 | $189 |
| GSK | 5 | $182 |
| Optinose US, Inc. | 10 | $154 |
| Integra Lifesciences Corporation | 5 | $126 |
| Idorsia Pharmaceuticals US Inc | 1 | $112 |
| Novartis | 1 | $94 |
| Sanofi | 3 | $92 |
| Inspire Medical Systems, Inc. | 2 | $63 |
| Lilly USA, LLC | 2 | $33 |
| Peerless Surgical Inc. | 1 | $33 |
| Eyevance Pharmaceuticals LLC | 2 | $30 |
| Kerecis Limited | 1 | $29 |
| Smith+Nephew | 2 | $29 |
| Vertex | 1 | $27 |
| Organogenesis Inc. | 1 | $26 |
| Medtronic | 1 | $23 |
| Acera Surgical, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Polynovo North America LLC | 1 | $19 |
| Merck | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $17 |
| Alk-abello, Inc | 1 | $15 |
| Acclarent, Inc | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QUVIVIQ$112
How this compares
Too few otolaryngology/facial plastic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 216 | $5,465 |
| Mometasone Furoate | 36 | $5,197 |
| Epinephrine | 17 | $3,781 |
| Fluticasone Propionate | 220 | $3,685 |
| Esomeprazole Magnesium | 43 | $1,033 |
| Olopatadine Hcl | 12 | $1,006 |
| Ipratropium Bromide | 24 | $853 |
| Famotidine | 74 | $850 |
| Doxycycline Hyclate | 46 | $599 |
| Omeprazole | 52 | $558 |
| Montelukast Sodium | 56 | $546 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $433 |
| Lansoprazole | 12 | $306 |
| Pantoprazole Sodium | 15 | $227 |
| Zolpidem Tartrate | 12 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Hikma Pharmaceuticals USAEpinephrine | $14 | $3,78117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few otolaryngology/facial plastic surgery providers in South Carolinaon file to place this against a meaningful peer group, so we don't.
Other otolaryngology/facial plastic surgery in Sumter
- Helen MosesSumter$1K
- Michael PetersLittle River$29K
- Thomas SellnerGreenville$3K
- Sheila PutmanMyrtle Beach$3K
- Nicholas LukacsFort Mill$1K
- Hans CarlsonGreenville$1K
- William GilesColumbia$947
- Gregory EsselmanAiken$822
- Joseph RussellNorth Charleston$728
- Adam AbramColumbia$547
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.